Related Experiment Video
Updated: May 2, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Hypoxia: a critical pathophysiological driver in respiratory inflammatory diseases
Bing Zhong1,2, Lan Yang3, Si-Lu Sun4
1Department of Otolaryngology-Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Hypoxia, driven by hypoxia-inducible factor 1α (HIF-1α), worsens inflammatory airway diseases by damaging barriers, altering immune responses, and accelerating remodeling. Targeting HIF-1α offers a unified approach for developing precise therapies.
Area of Science:
- Pulmonary Medicine
- Immunology
- Cellular Biology
Background:
- Hypoxia is a key factor in inflammatory airway diseases like asthma and COPD.
- Hypoxia-inducible factor 1α (HIF-1α) signaling is a central mechanism driving disease progression.
- Shared pathophysiological pathways exist across different inflammatory airway diseases due to hypoxia.
Purpose of the Study:
- To synthesize hypoxia-driven mechanisms common to inflammatory airway diseases.
- To establish a unifying framework for HIF-1α signaling in these diseases.
- To highlight therapeutic implications and guide the development of targeted interventions.
Main Methods:
- This review synthesizes existing literature on hypoxia and HIF-1α signaling in airway diseases.
- It analyzes shared mechanisms of hypoxia-induced inflammation and tissue remodeling.
- The study provides a cross-disease perspective on hypoxia pathways.
Main Results:
- Hypoxia, via HIF-1α, disrupts epithelial integrity and initiates inflammation.
- HIF-1α reprograms immune cells (eosinophils, T cells, macrophages) and alters cytokine profiles.
- Hypoxia accelerates airway remodeling, leading to airflow limitation and persistent inflammation.
Conclusions:
- Targeting HIF-1α is crucial for developing effective therapies for inflammatory airway diseases.
- Disease-tailored interventions are needed, considering distinct pathological features.
- Further translational and clinical research on hypoxia is essential to build an evidence base for practice.
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

